Inventor · disambiguated record
Bruce Kovacs
Also filed as: KOVACS BRUCE
9 granted patents·6 pending applications·18 citations·filing 2002–2025
81Inventor score
Files withLAPKO INC6AFECTA PHARMACEUTICALS INC3LAPKO INC DBA AFECTA PHARMACEUTICALS3AFECTA PHARMACEUTICALS1AFECTA PHARMACEUTICALS DRIVE1
Top patents by PatentIndex Score
15 records- 0175US11628154B2CCL5 inhibitorsLAPKO INC·Filed 2022·Granted Apr 18, 2023·0 cites·10 claims
- 0275US6613763B2Use of molindone to treat oppositional defiant disorder and conduct disorderMGI APPLIED GENOMICS·Filed 2002·Granted Sep 2, 2003·15 cites·14 claims
- 0373US11497724B2CCL5 inhibitorsLAPKO INC·Filed 2022·Granted Nov 15, 2022·0 cites·10 claims
- 0470US10940132B2CCL5 inhibitorsAFECTA PHARMACEUTICALS INC·Filed 2019·Granted Mar 9, 2021·1 cites·21 claims
- 0569US11318111B2CCL5 inhibitorsLAPKO INC·Filed 2021·Granted May 3, 2022·0 cites·18 claims
- 0664US11858876B2CCL2 inhibitorsLAPKO INC·Filed 2021·Granted Jan 2, 2024·0 cites·8 claims
- 0761US2022202796A1CXCL10 InhibitorsLAPKO INC DBA AFECTA PHARMACEUTICALS·Filed 2022·Application pending·0 cites
- 0858US2021338650A1CXCL10 InhibitorsLAPKO INC DBA AFECTA PHARMACEUTICALS·Filed 2021·Application pending·0 cites
- 0956US6897212B2Treatment of oppositional defiant disorder and conduct disorder with 5-aminoalkyl-4,5,6,7-tetrahydro-4-oxyindolonesAFECTA PHARMACEUTICALS·Filed 2003·Granted May 24, 2005·2 cites·17 claims
- 1055US2009318520A1Use of isoindoles for the treatment of neurobehavioral disordersAFECTA PHARMACEUTICALS DRIVE·Filed 2009·Application pending·0 cites
- 1153US11458184B2Compositions and methods for treating skin conditions, acne form lesions, and acneLAPKO INC·Filed 2021·Granted Oct 4, 2022·0 cites·20 claims
- 1246US2025186454A1Methods for treating aberrant behavior and motor activityLAPKO INC DBA AFECTA PHARMACEUTICALS·Filed 2025·Application pending·0 cites
- 1344US11130729B2CCL2 inhibitorsLAPKO INC·Filed 2018·Granted Sep 28, 2021·0 cites·15 claims
- 1440US2018098970A1Use of isoindoles for the treatment of neurobehavioral disordersAFECTA PHARMACEUTICALS INC·Filed 2017·Application pending·0 cites
- 1530US2020039922A1High mobility group b1 protein inhibitorsAFECTA PHARMACEUTICALS INC·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Bruce Kovacs files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →